DOI:
10.1055/s-00040811
Neurologie up2date
LinksClose Window
References
Kaley TJ, Wen P, Schiff D. et al.
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.
Neuro-Oncology 2015;
17: 116-121
DOI: 10.1093/neuonc/nou148.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.